1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Ear Care in Brazil

Ear Care in Brazil

  • July 2013
  • -
  • Euromonitor International
  • -
  • 24 pages

ANVISA (Brazilian Health Surveillance Agency) only permits a limited number of types of ear care products to be commercialised as OTC. Therefore, sales are limited to products designed to ease minor discomfort, which result from a build-up of ear wax or fluid accumulation.

Euromonitor International's Ear Care in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage:
Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

* Get a detailed picture of the Ear Care market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Table Of Contents

Ear Care in Brazil
EAR CARE IN BRAZIL



LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Ear Care: Value 2007-2012
Table 2 Sales of Ear Care: % Value Growth 2007-2012
Table 3 Ear Care Company Shares by Value 2008-2012
Table 4 Ear Care Brand Shares by Value 2009-2012
Table 5 Forecast Sales of Ear Care: Value 2012-2017
Table 6 Forecast Sales of Ear Care: % Value Growth 2012-2017
Executive Summary
Consumer Health Maintains Strong Growth
Anvisa Moves OTC Products Back To Over-the-counter
Hypermarcas Aims for Leadership
Internet Retailing: Potential Channel in Consumer Health
Consumer Health Is Expected To Maintain Its Growth Over the Forecast Period
Consumer Health Products Back To Over-the-counter
Hypermarcas Invests in Becoming the Leading Manufacturer
Middle-classes Continue To Positively Impact Consumer Health
Consumers' Health Awareness Shows Potential in Vitamins and Dietary Supplements
Illegal Sales Hamper Growth in Sports Nutrition
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 8 Life Expectancy at Birth 2007-2012
Market Data
Table 9 Sales of Consumer Health by Category: Value 2007-2012
Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 11 Consumer Health Company Shares 2008-2012
Table 12 Consumer Health Brand Shares 2009-2012
Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 15 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
De-reimbursement
Generics
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
Summary 1 Research Sources












View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...

Global Over The Counter (OTC) Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

Global Over The Counter (OTC) Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

  • $ 4250
  • Industry report
  • November 2016
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...

Global Over the Counter (OTC) Drugs Market

Global Over the Counter (OTC) Drugs Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...

Otc Drugs Markets In China

January 2017 $ 4000

Otc Drugs Companies In China

January 2017 $ 1800

Download Unlimited Documents from Trusted Public Sources

The future of the Pain Relief Industry in the UK

  • February 2017
    5 pages
  • Pain Relief  

  • United Kingdom  

View report >

OTC Industry in Spain

  • February 2017
    4 pages
  • Vitamin  

  • Spain  

View report >

OTC Market Segment in Japan

  • February 2017
  • OTC  

    Cement  

  • Japan  

View report >

Related Market Segments :

OTC
Vitamin

ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.